Level Biotechnology (3118) - Total Liabilities

Latest as of September 2025: NT$237.03 Million TWD ≈ $7.47 Million USD

Based on the latest financial reports, Level Biotechnology (3118) has total liabilities worth NT$237.03 Million TWD (≈ $7.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 3118 net asset momentum to track the company's year-over-year net asset growth rate.

Level Biotechnology - Total Liabilities Trend (2017–2024)

This chart illustrates how Level Biotechnology's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Level Biotechnology to measure how efficiently the company converts operating cash flow to free cash.

Level Biotechnology Competitors by Total Liabilities

The table below lists competitors of Level Biotechnology ranked by their total liabilities.

Company	Country	Total Liabilities
Yellow Balloon Tour Co. Ltd KQ:104620	Korea	₩84.79 Billion
Impresa - Sociedade Gestora de Participações Sociais S.A LS:IPR	Portugal	€250.78 Million
WINSON Machinery Co Ltd TWO:4538	Taiwan	NT$67.08 Million
Templeton Emerging Markets Investment Trust TEMIT LSE:TEM	UK	GBX125.19 Million
Sharps Technology Inc NASDAQ:STSS	USA	$10.75 Million
Kuk Dong KO:005320	Korea	₩59.57 Billion
Malton Bhd KLSE:6181	Malaysia	RM1.07 Billion
QT Imaging Holdings, Inc. Common Stock NASDAQ:QTI	USA	$16.58 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Level Biotechnology's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Level Biotechnology (3118) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.42	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Level Biotechnology's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Level Biotechnology (2017–2024)

The table below shows the annual total liabilities of Level Biotechnology from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$267.19 Million ≈ $8.42 Million	-2.20%
2023-12-31	NT$273.20 Million ≈ $8.61 Million	+1.14%
2022-12-31	NT$270.13 Million ≈ $8.51 Million	+11.27%
2021-12-31	NT$242.78 Million ≈ $7.65 Million	-0.32%
2020-12-31	NT$243.56 Million ≈ $7.67 Million	+3.01%
2019-12-31	NT$236.43 Million ≈ $7.45 Million	+30.19%
2018-12-31	NT$181.60 Million ≈ $5.72 Million	-13.53%
2017-12-31	NT$210.03 Million ≈ $6.62 Million	--

About Level Biotechnology

TWO:3118 Taiwan Biotechnology

Market Cap

$32.46 Million

NT$1.03 Billion TWD

Market Cap Rank

#23423 Global

#1465 in Taiwan

Share Price

NT$31.75

Change (1 day)

+0.32%

52-Week Range

NT$30.95 - NT$34.10

All Time High

NT$37.15